David Michael  Williams net worth and biography

David Williams Biography and Net Worth

Executive vice president, chief information & digital officer of Merck & Co., Inc.

Dave Williams is Merck’s chief information and digital officer. Under his direction the technology organization is focused on helping Merck’s research, manufacturing and business units develop and leverage digital solutions to serve customers and achieve business value. 

Previously, Dave was chief information officer of Merck Animal Health. There he led the development and execution of a digital transformation that deployed several cloud-based platforms and capabilities, resulting in streamlined operations and improved customer engagement. 

Prior to that, Dave founded Merck Animal Health Ventures, which brings together capabilities across veterinarians, start-ups, inventors, entrepreneurs, customers and investment partners to develop new solutions that address unmet customer needs. He also led Sure Petcare, a companion-animal portfolio of digital services and solutions within Merck Animal Health, where he had profit-and-loss responsibility. 

Earlier in his career, Dave was executive director of enterprise information management at Merck and held several IT leadership roles at Schering-Plough.

Dave currently serves on the board of the National Center for Women in Technology and is a member of the Osage Partners Advisory Council. 

He holds a bachelor of science in economics and finance from the University of Scranton.

What is David Michael Williams' net worth?

The estimated net worth of David Michael Williams is at least $3.57 million as of February 6th, 2026. Mr. Williams owns 30,838 shares of Merck & Co., Inc. stock worth more than $3,565,212 as of March 15th. This net worth approximation does not reflect any other assets that Mr. Williams may own. Learn More about David Michael Williams' net worth.

How old is David Michael Williams?

Mr. Williams is currently 55 years old. There are 7 older executives and no younger executives at Merck & Co., Inc.. The oldest executive at Merck & Co., Inc. is Mr. Sanat Chattopadhyay, Executive VP & President of Merck Manufacturing Division, who is 64 years old. Learn More on David Michael Williams' age.

How do I contact David Michael Williams?

The corporate mailing address for Mr. Williams and other Merck & Co., Inc. executives is 2000 GALLOPING HILL ROAD, KENILWORTH NJ, 07033. Merck & Co., Inc. can also be reached via phone at (908) 740-4000 and via email at [email protected]. Learn More on David Michael Williams' contact information.

Has David Michael Williams been buying or selling shares of Merck & Co., Inc.?

Within the last three months, David Michael Williams has sold $609,550.00 of Merck & Co., Inc. stock. Most recently, David Michael Williams sold 5,000 shares of the business's stock in a transaction on Friday, February 6th. The shares were sold at an average price of $121.91, for a transaction totalling $609,550.00. Following the completion of the sale, the executive vice president now directly owns 30,838 shares of the company's stock, valued at $3,759,460.58. Learn More on David Michael Williams' trading history.

Who are Merck & Co., Inc.'s active insiders?

Merck & Co., Inc.'s insider roster includes Sanat Chattopadhyay (Insider), Frank Clyburn (EVP), Robert Davis (CFO), Richard Deluca (EVP), Cristal Downing (Insider), Kenneth Frazier (Insider), Julie Gerberding (EVP), Clark Golestani (EVP), Chirfi Guindo (CMO), Michael Holston (EVP), E III (SVP), Rita Karachun (VP), Dean Li (VP), Caroline Litchfield (CFO), Steven Mizell (EVP), Johannes Oosthuizen (Insider), Joseph Romanelli (Insider), Inge Thulin (Director), Ashley Watson (SVP), Wendell Weeks (Director), David Williams (Executive vice president, chief information & digital officer), and Jennifer Zachary (EVP). Learn More on Merck & Co., Inc.'s active insiders.

Are insiders buying or selling shares of Merck & Co., Inc.?

During the last year, insiders at the sold shares 12 times. They sold a total of 333,052 shares worth more than $39,354,502.05. The most recent insider tranaction occured on February, 9th when CMO Chirfi Guindo sold 10,000 shares worth more than $1,184,100.00. Insiders at Merck & Co., Inc. own 0.1% of the company. Learn More about insider trades at Merck & Co., Inc..

Information on this page was last updated on 2/9/2026.

David Michael Williams Insider Trading History at Merck & Co., Inc.

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/6/2026Sell5,000$121.91$609,550.0030,838View SEC Filing Icon  
11/3/2025Sell8,614$83.59$720,044.2624,578View SEC Filing Icon  
See Full Table

David Michael Williams Buying and Selling Activity at Merck & Co., Inc.

This chart shows David Michael Williams's buying and selling at Merck & Co., Inc. by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Merck & Co., Inc. Company Overview

Merck & Co., Inc. logo
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Read More

Today's Range

Now: $115.61
Low: $115.53
High: $117.89

50 Day Range

MA: $115.26
Low: $106.94
High: $124.11

2 Week Range

Now: $115.61
Low: $73.31
High: $125.14

Volume

7,058,649 shs

Average Volume

9,573,144 shs

Market Capitalization

$285.84 billion

P/E Ratio

15.88

Dividend Yield

2.94%

Beta

0.27